GLUE |
Monte Rosa Therapeutics, Inc. |
Dec 11, 2024 |
1 |
$0 |
4 |
Dec 13, 2024 |
Director |
GLUE |
Monte Rosa Therapeutics, Inc. |
Dec 11, 2024 |
0 |
$0 |
3 |
Dec 13, 2024 |
Director |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Aug 9, 2024 |
1 |
-$783K |
4 |
Aug 13, 2024 |
Executive Vice President, Global R&D and Chief Medical Officer |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Aug 1, 2024 |
3 |
-$423K |
4 |
Aug 5, 2024 |
Executive Vice President, Global R&D and Chief Medical Officer |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Mar 3, 2024 |
4 |
-$107K |
4 |
Mar 5, 2024 |
Executive Vice President, Global R&D and Chief Medical Officer |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Aug 1, 2023 |
3 |
-$438K |
4 |
Aug 3, 2023 |
Executive Vice President, Global R&D and Chief Medical Officer |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Mar 3, 2023 |
1 |
$0 |
4 |
Mar 7, 2023 |
Executive Vice President, Global R&D and Chief Medical Officer |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Aug 1, 2022 |
1 |
$0 |
4 |
Aug 3, 2022 |
Executive Vice President, Global R&D and Chief Medical Officer |
TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
Aug 1, 2022 |
0 |
$0 |
3 |
Aug 3, 2022 |
Executive Vice President, Global R&D and Chief Medical Officer |